Datamonitor & Biospace Logo
  Basket Contents Checkout


Rx-to-OTC Strategies: Maximizing the Commercial Potential of an Rx-to-OTC Switch

Quantity in Basket: none

Price: $5,700.00
Report Format: PDF
Date Published: 26-Jun-08
Product Type: Premium Report
Table of Contents:

View Table of Contents

Introduction
With the growing cost of developing novel drugs, combined with the fact that fewer such drugs are gaining regulatory approval, the use of lifecycle management is playing an ever-more important role in the increasingly cost-conscious pharma industry. Rx-to-OTC switching is one such strategy employed to either enhance existing franchise revenues or protect branded revenues from generic competition.


Scope
  • Overview of the Rx-to-OTC strategy, analyzing why, when, where, what and how to implement such a switch strategy
  • Identification of drivers and resistors of Rx-to-OTC switching across the seven major pharmaceutical markets
  • Case study analysis of the most recent Rx-to-OTC switches

  • Report Highlights
    For Rx-to-OTC switches to succeed, there needs to sufficient differentiation between the existing Rx drug and the new OTC product. However, differentiation must meet a genuine unmet need. Differentiation for the sake of it is unlikely to produce a winning Rx-to-OTC switch strategy.

    The volume of the OTC market is declining in the majority of the seven major markets. If this trend continues, it will not only impact the profits of OTC manufacturers, but also national cost-containment measures to reduce ever-escalating healthcare costs.

    At present, Rx-to-OTC switches in the five major EU markets are decided at a national level. However, despite ongoing discussions, there are numerous barriers to harmonized EU Rx-to-OTC switches. Consequently, it is unlikely that in the EU harmonization will happen at least in the foreseeable future.


    Reasons to Purchase
  • Identify the recent trends in the Rx-to-OTC market, including which are the most popular OTC indications, and who is implementing Rx-to-OTC switches
  • Gain insight into the drivers and resistors of implementing Rx-to-OTC switches across the seven major markets
  • Recommendations on how to maximize the commercial success of an Rx-to-OTC switch

  • Table of Contents
    Please click on the link below to view further information on this product (a new window will open):

    View Table of Contents


    If you require further information on this product or would like to purchase by invoice call our customer service number:
    (+1) 800-759-0261 or Email us.

     


    If you require assistance please Email us or call +1-800-759-0261.